DenovAI Biotech Ltd.
Digital Health — Stage: R&D. Est: 2023. Tags: Artificial Intelligence, Computational Biology, Digital Health, Generative AI, Healthtech, Life Sciences, Machine Learning, MedTech. DenovAI is a developer of gen artificial intelligence (AI)-physics platform for the de-novo design of therapeutic proteins, including antibodies and mini-proteins. The company's platform designs antibodies from scratch and then suggests which candidates will likely make effective drugs, enabling medical professionals to transform human health into new standards, accelerating drug discovery timelines, and addressing unmet medical needs with accurately designed molecules.. Web: https://denovai.com